New Hyde Park, NY2 Active Studies

Interstitial Cystitis Clinical Trials in New Hyde Park, NY

Find 2 actively recruiting interstitial cystitis clinical trials in New Hyde Park, NY. Connect with local research sites and explore new treatment options.

2
Active Trials
2
Sponsors
154
Enrolling

Recruiting Interstitial Cystitis Studies in New Hyde Park

About Interstitial Cystitis Clinical Trials in New Hyde Park

Interstitial cystitis/bladder pain syndrome is a chronic condition causing bladder pressure, bladder pain, and sometimes pelvic pain. It primarily affects women and can significantly impact quality of life. Treatment includes dietary changes, bladder instillations, oral medications, and neuromodulation.

There are currently 2 interstitial cystitis clinical trials recruiting participants in New Hyde Park, NY. These studies are seeking a combined 154 participants. Research is being sponsored by K36 Therapeutics, Inc., Northwell Health. Clinical trial participation is free and participants receive study-related medical care at no cost.

Interstitial Cystitis Clinical Trials in New Hyde Park — FAQ

Are there interstitial cystitis clinical trials in New Hyde Park?

Yes, there are 2 interstitial cystitis clinical trials currently recruiting in New Hyde Park, NY. Browse the studies on this page to find one that fits.

How do I join a clinical trial in New Hyde Park?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the New Hyde Park research site will contact you about next steps.

Are clinical trials in New Hyde Park free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many New Hyde Park studies also compensate for your time and travel.

What interstitial cystitis treatments are being tested?

The 2 active trials in New Hyde Park are testing new therapies including novel drugs, biologics, and treatment approaches for interstitial cystitis.

Data updated September 5, 2026 from ClinicalTrials.gov